Inozyme Pharma Prices Public Offering Of 12.5M Common Stock At $4.80/Share
Portfolio Pulse from Benzinga Newsdesk
Inozyme Pharma has priced its public offering of 12.5 million common stocks at $4.80 per share.
July 28, 2023 | 6:28 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Inozyme Pharma's public offering of 12.5 million common stocks is priced at $4.80 per share.
The pricing of Inozyme Pharma's public offering could potentially impact the company's stock price. However, the direction of the impact is uncertain as it depends on various factors such as investor sentiment, market conditions, and the company's financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100